Artandi's laboratory at Stanford has shown that mTERT can not only augment breast cancer development in mice but that it regulates the transcription of genes responsive to the Wnt/beta catenin pathway.113, 114. The gene discussed is CTNNB1; the disease is breast carcinoma.